orphan drug, reimbursement policy, Central and East Europe, European Medicine Agency, kappa coefficient of agreement, marketing authorisation, exceptional circumstances, conditional approval
departmental parameterization:
100
affiliation:
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego